- Garcitrin® is a patented weight management product
- Garcitrin® is the third Sabinsa product which received the Thomas Alva Edison Patent Award
- Garcitrin® constituents are phytonutrients, which are derived from Garcinia cambogia
- The active compounds are the calcium salt of (‐) hydroxycitric acid (HCA) and garcinol
- Garcitrin® contains 50 to 60% of (‐) HCA, 18 to 20% of calcium and 5 to 7% of garcinol
- Garcinia cambogia plant constituents are obtained from Garcinia cambogia and Garcinia indica which are cultivated in Southern India
- (-) HCA competes with citrate for the enzymatic activity of ATP citrate lyase in the cytoplasm. As a result, less acetyl coenzyme A is formed from citrate. Acetyl coenzyme A is a major precursor of fatty acids and malonyl coenzyme A. Because of it, Garcitrin®
- Suppresses lipogenesis *
- Stimulates the metabolic rate of fat burning *
- Diminishes appetite *
- A double‐blind clinical study reported that a combination of (-) HCA with garcinol is more potent than (‐)HCA is alone in weight loss
- Visit www.garcitrin.com/clinicalfor details of the study
- (-) HCA competes with citrate for the enzymatic activity of ATP citrate lyase in the cytoplasm. As a result, less acetyl coenzyme A is formed from citrate. Acetyl coenzyme A is a major precursor of fatty acids and malonyl coenzyme A. Because of it, Garcitrin®
- Suppresses lipogenesis *
- Stimulates the metabolic rate of fat burning *
- Diminishes appetite *
- Yes, clinical studies have shown the potency of Garcitrin® in weight loss
- The results also demonstrated that Garcitrin® is more efficient than (‐) HCA is alone
- Preclinical studies conducted in laboratory animals using (‐) HCA alone and (-)HCA combining with garcinol
- No serious side effects nor adverse effects have been reported
- Yes, Garcitrin® ingredients are extracted from sustainably-grown Garcinia cambogia
- No, Garcitrin® is not a genetically‐modified organism
- Sabinsa’s most ingredients are Kosher and Halal certified as well as Allergen- free
- Yes, Garcitrin® is an Old Dietary Ingredient.
- Garcitrin® can therefore be marketed immediately, without the need for pre-market NDI notification
- The suggested dose is 500 mg of extract 30 min to 1 hr before meals‐3 times daily
- Sabinsa’s manufacturing facilities (located in India) are operated according to cGMP
- They are FDA‐inspected and passed
- Yes, Garcitrin® is a globally patented and trademarked product
- Please see www.garcitrin.com/patents/
- For more information visit www.garcitrin.com